Stock Analysis
OrganoClick (STO:ORGC) First Quarter 2024 Results
Key Financial Results
- Revenue: kr38.2m (down 12% from 1Q 2023).
- Net loss: kr2.11m (loss widened by 112% from 1Q 2023).
- kr0.022 loss per share (further deteriorated from kr0.01 loss in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
OrganoClick Earnings Insights
Looking ahead, revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Sweden.
Performance of the Swedish Chemicals industry.
The company's shares are up 3.1% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 1 warning sign for OrganoClick that you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether OrganoClick is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About OM:ORGC
OrganoClick
A green chemical company, develops, manufactures, and sells biobased chemical products for the treatment of technical textile, nonwoven, and wood in Sweden, Other Nordics, The Rest of Europe, Asia, and North America.
High growth potential with mediocre balance sheet.